Target intelligence / Profile preview

Oral bacterial biofilms and pathogenic bacteria

Molecular classification
Other
01

Overview

Oral bacterial biofilms, frequently referred to as dental plaque, are structured communities of microorganisms adhering to tooth surfaces and encapsulated within a self-produced matrix of extracellular polymeric substances (EPS) (Marsh, 2006). These biofilms represent a highly organized ecosystem where diverse bacterial species, such as Streptococcus mutans and Porphyromonas gingivalis, communicate via quorum sensing and share genetic material (Kolenbrander et al., 2010). In a healthy state, the oral microbiota exists in symbiosis with the host; however, ecological shifts can lead to the dominance of pathogenic bacteria, resulting in dental caries and periodontal diseases (Lamont et al., 2018). Therapeutic interventions aim to disrupt these biofilms through mechanical debridement or pharmacological agents like chlorhexidine and fluoride, which target bacterial cell walls or metabolic pathways (Seneviratne et al., 2011). Effective management of oral biofilms is essential for maintaining oral health and reducing the risk of systemic complications, including cardiovascular disease and diabetes, which have been linked to chronic oral infections (NIH/NIDCR).

Other names
Dental plaqueOral microbiotaDental biofilmOral pathogens
02

Mechanism of action

Disruption of cell membrane integrity, inhibition of bacterial enzymes, interference with DNA replication, and degradation of the extracellular matrix.

03

Biological functions

Other
04

Disease associations

InfectionOther
05

Safety considerations

Antimicrobial resistanceOral dysbiosisTooth stainingLocal irritationSystemic toxicity (e.g., fluoride overdose)
06

Interacting drugs

Chlorhexidine

6 more in the full profile.

07

Biomarkers

Plaque Index (PI)Gingival Index (GI)Streptococcus mutans countPorphyromonas gingivalis countProbing pocket depth (PPD)Bleeding on probing (BOP)

Beyond the preview

Go deeper on Oral bacterial biofilms and pathogenic bacteria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral bacterial biofilms and pathogenic bacteria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call